The immune checkpoint inhibitors market is estimated to be worth $12 billion in 2030 and is expected to grow at CAGR of 15% during the forecast period.
The cancer biomarker market size is projected to grow from $ 28.6 billion in 2024 to $ 46.7 billion by 2035, representing a CAGR of 5% during the forecast period from 2024 to 2035